Keyphrases
Spinal Cord Injury
100%
Randomized Controlled Trial
100%
Teriparatide
100%
Bone Mass
100%
Bone Strength
100%
Bone Loss
100%
Areal Bone Mineral Density (aBMD)
40%
Spine
30%
Chronic Spinal Cord Injury
20%
Knee
20%
Cortical Bone
20%
Treatment Effect
10%
Placebo
10%
Sham
10%
Clinical Benefit
10%
Specific Response
10%
Serum Markers
10%
Treatment Group
10%
Fracture Risk
10%
Location-specific
10%
Bone Evaluation
10%
Finite Element
10%
Treatment Improvement
10%
Low Bone Mass
10%
Open-label Extension
10%
Confirmatory Data
10%
Bone Metabolism Markers
10%
Procollagen Type 1 N-terminal Propeptide (P1NP)
10%
Computed Tomography Measurement
10%
Vibration Stimulation
10%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Bone Mass
100%
Bone Density
100%
Bone Strength
100%
Osteolysis
100%
Bone Remodeling
25%
Computer Assisted Tomography
25%
Transcription Factor PAX5
25%
Neuroscience
Randomized Controlled Trial
100%
Teriparatide
100%
Spinal Cord Injury
100%
Vertebral Column
30%
Computed Tomography
10%
Transcription Factor PAX5
10%
Metabolic Pathway
10%
Placebo
10%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Spinal Cord Injury
100%
Parathyroid hormone[1-34]
100%
Placebo
10%
Transcription Factor PAX5
10%